MiniMed Expands Sensor Portfolio in Europe with CE Mark for MiniMed 780G

Summary

MiniMed Group, Inc. received CE Mark approval for its MiniMed 780G automated insulin delivery system to be used with Abbott's Instinct continuous glucose monitor, adding a 15‑day wear sensor to the existing 7‑day options (Guardian 4 and Simplera Sync). The Instinct sensor is the smallest, thinnest CGM on the market, extending wear time to up to 15 days and giving users greater flexibility. MiniMed plans a summer rollout of the combined system in its first European markets and will showcase it at the ATTD 2026 conference in Barcelona. The system is CE‑marked for patients aged 2 and older, including use during pregnancy, while U.S. approvals remain more limited.